help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fink, R. S.
Right arrow Articles by Honour, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fink, R. S.
Right arrow Articles by Honour, J. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
Medline Plus Health Information
*Steroids
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 10 4541-4546
Copyright © 2002 by The Endocrine Society


Original Article

Hypothalamic-Pituitary-Adrenal Axis Function after Inhaled Corticosteroids: Unreliability of Urinary Free Cortisol Estimation

Richard S. Fink, Lisa N. Pierre, Peter T. Daley-Yates, David H. Richards, Anthony Gibson and John W. Honour

Chemical Pathology Department, West Middlesex University Hospital/Quest Diagnostics, Inc., Isleworth, Middlesex, United Kingdom TW7 6AF; Clinical Pharmacology, GlaxoSmithKline Research and Development, Greenford, Middlesex, United Kingdom UB6 0HE; Respiratory Therapeutic Group, GlaxoSmithKline, Uxbridge, United Kingdom UB11 1BT; and Department of Chemical Pathology, University College London Hospitals, London, United Kingdom W1T 4JF

Address all correspondence and requests for reprints to: Dr. R. Fink, West Middlesex University Hospital/Quest Diagnostics, Inc., Chemical Pathology Department, Isleworth, Middlesex, United Kingdom TW7 6AF. E-mail: richard.s.fink{at}questdiagnostics.com.

Abstract

Free cortisol in the urine (UFC) is frequently measured in clinical research to assess whether inhaled corticosteroids (ICS) cause suppression of the hypothalamic-pituitary-adrenal axis. Thirteen healthy male subjects received single inhaled doses (of molar equivalence) of fluticasone propionate (FP), triamcinolone acetonide (TAA), budesonide (BUD), and placebo in this single blind, randomized, cross-over study. UFC output was measured using four commercial immunoassays in samples collected in 12-h aliquots over 24 h. The cortisol production rate was assessed from the outputs of cortisol metabolites. UFC showed a 100% increase over placebo levels in the Abbott TDX assay after the administration of BUD. The other assays detected variable suppression (ranging from 29–61% suppression for FP, 30–62% suppression for TAA, and 25% suppression to 100% stimulation for BUD). Suppression was more pronounced in the first 12 h after TAA and in the second 12 h after FP. Similar suppression was found in each 12-h period after BUD. UFC estimation based on immunoassays after ICS may be an unreliable surrogate marker of adrenal suppression. Many of the published studies describing or comparing the safety of different ICS should be reevaluated, and some should be interpreted with caution.




This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Masoli, M. Weatherall, S. Holt, P. Shirtcliffe, and R. Beasley
Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis
Eur. Respir. J., November 1, 2006; 28(5): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
W. K. Jerjes, N. F. Taylor, T. J. Peters, S. Wessely, and A. J. Cleare
Urinary Cortisol and Cortisol Metabolite Excretion in Chronic Fatigue Syndrome
Psychosom Med, July 1, 2006; 68(4): 578 - 582.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. P. Chrousos, L. Ghaly, A. Shedden, D. G. Iezzoni, and A. G. Harris
Effects of Mometasone Furoate Dry Powder Inhaler and Beclomethasone Dipropionate Hydrofluoroalkane and Chlorofluorocarbon on the Hypothalamic-Pituitary-Adrenal Axis in Asthmatic Subjects
Chest, July 1, 2005; 128(1): 70 - 77.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. Pescollderungg, D. G. Peroni, A. Pietrobelli, and G. Radetti
Inhaled Corticosteroids and Urinary Free Cortisol
Pediatrics, December 1, 2003; 112(6): 1464 - 1465.
[Full Text] [PDF]


Home page
ThoraxHome page
L Pescollderungg, G Radetti, E Gottardi, D G Peroni, A Pietrobelli, and A L Boner
Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test
Thorax, March 1, 2003; 58(3): 227 - 230.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society